Frontera Therapeutics
Committed to Advancing Human Health
Bedford · Founded 2019 · $195.0M raised
- Headquarters
- Bedford, Massachusetts
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- fronteratherapeutics.com
- Total Funding
- $195.0M
- Last Round
- $160.0M Series BJun 2022
- Rounds
- 2
About
Frontera Therapeutics is a clinical-stage gene therapy company developing rAAV-based therapies for ophthalmic, cardiovascular, and neurological diseases. Founded 2019 in Bedford MA.
Summary
Frontera Therapeutics is a Biotech company based in Bedford, founded in 2019. It has raised $195.0M in total across 2 rounds, most recently a $160.0M Series B round in Jun 2022. Investors include OrbiMed, Creacion Ventures and Boyu Capital.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2022
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...